Literature DB >> 21643805

Histopathologic and immunohistochemical profile of spinal glioblastoma: a study of six cases.

Aparna Govindan1, Shrijeet Chakraborti, Anita Mahadevan, Yasha T Chickabasavaiah, Vani Santosh, S K Shankar.   

Abstract

Spinal intramedullary glioblastomas are uncommon tumors and are known to have a very poor prognosis. Only a few studies in the literature have described their histopathological characteristics. We describe the detailed histopathological and immunohistochemical profiles of six cases of spinal glioblastoma. Most of the tumors were located in the cervical or cervicothoracic region. The majority of the patients were young adults (mean age 34.8 years), presenting with a short duration of symptoms of 2 months or less. Their histopathological features were similar to cerebral glioblastoma. Diverse vascular changes like microvascular proliferation, sprouting angiogenesis, sclerosed and thrombosed vessels, along with field necrosis were prominent findings. All tumors were positive for GFAP and negative for EMA. The MIB-1 labeling index was very high (mean 16.7 ± 3.2%). Five out of six tumors were immunoreactive for p53 protein, and only two showed over-expression of EGFR protein. The predominant expression of p53 in these young patients suggests that spinal glioblastomas are similar to secondary glioblastoma in the cerebral hemispheres, despite the short duration of symptoms in them and vascular changes that are similar to those noted in primary glioblastoma. These observations support the fact that spinal glioblastomas are heterogeneous tumors underlined by complex molecular pathways. Nevertheless, inactivation of the p53 tumor suppressor pathway could play a major role in the genesis of these neoplasms.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21643805     DOI: 10.1007/s10014-011-0041-5

Source DB:  PubMed          Journal:  Brain Tumor Pathol        ISSN: 1433-7398            Impact factor:   3.298


  6 in total

Review 1.  Spinal cord tumours: advances in genetics and their implications for treatment.

Authors:  Patricia L Zadnik; Ziya L Gokaslan; Peter C Burger; Chetan Bettegowda
Journal:  Nat Rev Neurol       Date:  2013-03-26       Impact factor: 42.937

2.  The involvement of hematopoietic pre-B cell leukemia transcription factor-interacting protein in regulating epithelial-mesenchymal transition of human spinal glioblastoma.

Authors:  Deliang Wang; Li Wang; Yi Zhou; Xinjun Zhao; Hui Xiong
Journal:  Tumour Biol       Date:  2015-11-21

3.  Glioblastoma multiforme in conus medullaris with intracranial metastasis after postoperative adjuvant therapy.

Authors:  Chengrui Yan; Xiangyi Kong; Hua Yin; Yu Wang; Huayu He; Hui Zhang; Jun Gao; Yongning Li; Wenbin Ma
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

4.  Molecular Biomarkers of Brain and Spinal Cord Astrocytomas.

Authors:  N A Konovalov; D S Asyutin; E G Shayhaev; S V Kaprovoy; S Yu Timonin
Journal:  Acta Naturae       Date:  2019 Apr-Jun       Impact factor: 1.845

Review 5.  Surgical approaches to intramedullary spinal cord astrocytomas in the age of genomics.

Authors:  Andrew M Hersh; George I Jallo; Nir Shimony
Journal:  Front Oncol       Date:  2022-09-06       Impact factor: 5.738

6.  Surgical treatment and neurological outcome of infiltrating intramedullary astrocytoma WHO II-IV: a multicenter retrospective case series.

Authors:  Vicki M Butenschoen; Vanessa Hubertus; Insa K Janssen; Julia Onken; Christoph Wipplinger; Klaus C Mende; Sven O Eicker; Victoria Kehl; Claudius Thomé; Peter Vajkoczy; Karl Schaller; Jens Gempt; Bernhard Meyer; Maria Wostrack
Journal:  J Neurooncol       Date:  2020-10-22       Impact factor: 4.130

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.